News / Events

Digitalization - Which chances does it conceal?


Meet our experts on September, 12th, in Munich.

Process optimization through digitalization - new trends, their benefits, regulatory requirements and application examples are presented at the Digital Life Science Day. Besides trend studies and presentations, discussions and a Get-together with experts of Thescon, the host Capgemini and the technology company PTC Inc. awaiting the participants.

Read more

Artificial intelligence from IT compliance point of view - can you control AI?


PTS seminar invites to a discussion with experts

On September, 24th, a PTS seminar in Wiesbaden will address the topic ‘artificial Intelligence in pharma industry’. One of the speakers is Ingo Baumann, partner of Thescon GmbH, who will discuss possibilities and limits of controllability as well as compatibility of AI and IT Compliance.

Read more

Qualified Person - current challenges & practical realisation


Oxaion offers product presentations and independent expert talks

Meet Eric Strelow, partner at Thescon GmbH, and Dr. Marvin Birka, senior consultant and compliance expert at Thescon, at the medical device day in Stuttgart on July 4, 2019. Discuss with us about chances and risks of digitalisation, integration of IT processes in QM systems and pragmatic implementations of IT compliance requirements.

Read more

PTS webinar answers questions about serialization


Dr. Dmitrij Lisak shares his knowledge and practical experience

On June, 25th, PTS offers the possibility to join a webinar on serialization. Main topics comprise recent developments after Go Live, handling of batch releases, aggregation and returns.

Read more

New online service available


Thescon publishes white papers

White papers and Webinars about current topics are henceforth available on our website as free downloads.

Read more

Serialisation in Europe - next step Track & Trace?


Crypto codes, aggregation, Track & Trace - merely a matter of time?

Implementation regulations regarding serialisation differ between international markets. Which international trends can be expected to become valid in Europe? Dr. Dmitrij Lisak, serialisation expert and senior consultant at Thescon, shares his perceptions and expectations.

Read more

Qualified Person - current challenges & practical realisation


Meet Thescon at the QP conference on May 7th in Düsseldorf.

Dr. Dmitrij Lisak, senior consultant at Thescon, is one of the speakers who will introduce you to topics such as responsibilities, regulation, serialisation and batch releases.

Read more

ERP system changeover - Experiences from medical technology


Company shares knowledge after successful project closure

After changeover of their ERP system, the company “Inpac Medizintechnik GmbH” shares recommendations and gives advice for a successful project realization. The project was supported by the validation partner Thescon.

Read more

Serialization in Russia


Which points need to be considered?

By 2020, serialization will also be required in Russia. What are the main differences between the requirements in Russia and Europe?

Read more

First serialization inspections


FDA publishes first warning letter

Serialisation is mandatory in Europe since February, 9th, 2019. The American counterpart, the drug supply chain security act (DSCSA), came into force in November 2017. Recently, the FDA published a first warning letter that addresses this guideline

Read more

Agile project management


Meet Thescon at the 34. GAMP D-A-CH forum meeting.

Dr. Anne Tzschichholz presents a case study in agile project management at the GAMP D-A-CH forum meeting in March, 13th in Weilburg.

Read more

Data Integrity - Annoyance or opportunity?


Meet Thescon at the 24th GQMA Annual Meeting on March 27th 2019 in Berlin

Ingo Baumann, Thescon Partner and Senior Compliance Advisor, speaks about data integrity at the 24th GQMA Annual Meeting

Read more

A new partner within Thescon GmbH


A new partner within Thescon GmbH

Daniel Haas is the new internal partner at Thescon GmbH. We've asked him some questions and received interesting answers.

Read more